Suchergebnisse - "Tammemagi, Martin"

PubPharm (141)

1

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

enthalten in: bioRxiv.org | 2024

von Robbins, H. | Alcala, K. | Khodayari Moez, E. | +52

2

Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches

enthalten in: bioRxiv.org | 2024

von Warkentin, M. | Al-Sawaihey, H. | Lam, S. | +11

3

Risk-based lung cancer screening performance in a universal healthcare setting

enthalten in: Nature medicine | 2024

von Tammemägi, M. | Darling, G. | Schmidt, H. | +41

4

Perspective on Management of Low-Dose Computed Tomography Findings on Low-Dose Computed Tomography Examinations for Lung Cancer Screening. From the International Association for the Study of Lung Cancer Early Detection and Screening Committee

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Henschke, C. | Huber, R. | Jiang, L. | +25

5

Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches

enthalten in: Thorax | 2024

von Warkentin, M. | Al-Sawaihey, H. | Lam, S. | +12

6

Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model

enthalten in: Cancer | 2024

von Choi, E. | Luo, S. | Ding, V. | +17

7

Risk prediction models for lung cancer in people who have never smoked : a protocol of a systematic review

enthalten in: Diagnostic and prognostic research | 2024

von Issanov, A. | Aravindakshan, A. | Puil, L. | +3

8

Time to quit using quit time as a lung cancer screening eligibility criterion

enthalten in: Cancer | 2024

von Tammemägi, M.

CommentOn: Cancer. 2024 Jan;130(2):244-255. - PMID 37909874

9

Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous

enthalten in: Cancer | 2023

von Tammemägi, M. | Cina, K. | Kitts, A. | +4

10

Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US

enthalten in: JAMA oncology | 2023

von Choi, E. | Ding, V. | Luo, S. | +17

CommentOn: JAMA Oncol. 2023 Dec 1;9(12):1649-1650. - PMID 37883100

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]